Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Aligos Therapeutics Inc (NQ: ALGS )

32.85 -1.35 (-3.95%)
Official Closing Price Updated: 4:00 PM EST, Jan 22, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 75,100
Open 34.06
Bid (Size) 25.00 (10)
Ask (Size) 45.00 (1)
Prev. Close 34.20
Today's Range 32.22 - 34.06
52wk Range 12.82 - 37.51
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Aligos Therapeutics to Present at the 39th Annual J.P. Morgan Healthcare Conference
From GlobeNewswire News Releases
Aligos Therapeutics Presents Update on Development of SARS-CoV-2 Therapeutic Candidate and Screening Method in Collaboration with KU Leuven at RespiDART & Emerging Viruses 2020
From GlobeNewswire News Releases

Performance

YTD
+21.89%
+21.89%
1 Month
+22.26%
+22.26%
3 Month
+117.98%
+117.98%
6 Month
+121.21%
+121.21%
1 Year
+121.21%
+121.21%

More News

Read More
Aligos Enters into an Exclusive License and Research Collaboration Agreement with Merck to Discover and Develop an Oligonucleotide Therapy for NASH
From GlobeNewswire News Releases
Aligos Therapeutics Presents Data on Chronic Hepatitis B, NASH and Hepatocellular Carcinoma Programs at AASLD’s The Liver Meeting Digital Experience™ 2020
From GlobeNewswire News Releases
Aligos Therapeutics Announces Presentations at the Jefferies Virtual London Healthcare Conference & the Piper Sandler Annual Healthcare Conference
From GlobeNewswire News Releases
Aligos Therapeutics is awarded €1.8M VLAIO grant to advance chronic hepatitis B research
From GlobeNewswire News Releases
Aligos Therapeutics Doses First Subject in Phase 1 Proof-of-Concept Study of Small Molecule Drug Candidate ALG-000184 for Chronic Hepatitis B
From GlobeNewswire News Releases
Aligos Therapeutics Reaches Analyst Target Price
Tags ETFs
From ETF Channel
Wednesday 10/21 Insider Buying Report: CDAK, ALGS
Tags Stocks
From Market News Video
The Daily Biotech Pulse: Addex Jumps On Positive Data For Out-Licensed Drug, COVID-19 Vaccine Developer Inovio Announces $150M Follow-On Offering, Boston Scientific Goes Shopping
Tags NVTA ALIM M&A
From Benzinga
The Daily Biotech Pulse: DBV's Positive FDA Feedback, Pfizer's Cancer Drug Gets Label Expansion, Applied DNA COVID Testing Volume Surges
Tags BNGO BCAB LMAT
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.